Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zivo Bioscience's ebitda for the twelve months ending Jun 30, 2021 was -$8.95M. For fiscal 2021 it was -$8.65M. The highest annual figure on record is -$1.85M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$8.65M | – |
| FY2020 | Dec 31, 2020 | -$8.56M | – |
| FY2019 | Dec 31, 2019 | -$8.35M | – |
| FY2018 | Dec 31, 2018 | -$6.13M | – |
| FY2017 | Dec 31, 2017 | -$6.31M | – |
| FY2016 | Dec 31, 2016 | -$3.47M | – |
| FY2015 | Dec 31, 2015 | -$3.03M | – |
| FY2014 | Dec 31, 2014 | -$5.13M | – |
| FY2013 | Dec 31, 2013 | -$3.09M | – |
| FY2012 | Dec 31, 2012 | -$2.01M | – |
| FY2011 | Dec 31, 2011 | -$1.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | -$1.75M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.36M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.41M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.77M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.57M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$967.85K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.60M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$875.20K | – |
| Q1 FY2017 | Mar 31, 2017 | -$785.02K | – |
| Q4 FY2016 | Dec 31, 2016 | -$636.41K | – |
| Q3 FY2016 | Sep 30, 2016 | -$670.87K | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.52M | – |
| Q1 FY2016 | Mar 31, 2016 | -$634.31K | – |
| Q4 FY2015 | Dec 31, 2015 | -$657.50K | – |
See a number that looks wrong?